Live Breaking News & Updates on Ovaxin

Stay informed with the latest breaking news from Ovaxin on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Ovaxin and stay connected to the pulse of your community

Driven by XBB.1.16, India Sees Massive Jump of 10,158 New Covid Cases; Count May Rise for Next 10-12 Days

India has registered a single-day rise of 10,158 new coronavirus infections. The current rise in Covid cases is being driven by XBB.1.16, which is a sub variant of Omicron

India , Adar-poonawalla , Union-health-ministry , Serum-institute-of-india , Serum-institute , Latest-india-news , Covid-19 , Oronavirus , Elhi , Umbai , Ovishield , Ovaxin

Covid-19: Bharat Biotech to launch intranasal vaccine on January 26

This was the first intranasal vaccine to get the DCGI’s approval for primary immunisation of adults against the coronavirus.

Bhopal , Madhya-pradesh , India , Bharat , Krishna-ella , India-international-science-festival , Bharat-biotech , Republic-day , Drugs-controller-general , Ealth , Ovid-19 , Oronavirus

Expert panel recommends emergency use approval for Covaxin in 2-18 age group

Experts recommended granting emergency use authorisation to Covaxin for children and adolescents. It has been forwarded to DCGI for final approval.

Hyderabad , Andhra-pradesh , India , Bharat , Zydus-cadila , Expert-committee , Central-drugs-standard-control-organisation , Bharat-biotech , Drugs-controller-general , Subject-expert-committee , Whole-virion , Package-insert

Incovacc: How to book online appointment for this Covid nasal vaccine

Government of India announced Incovacc, a nasal COVID developed by Bharat Biotech and is available in private vaccination centres. The slots for the nasal vaccine can be booked by Cowin website.

India , Bharat , Incovacc-covid , Bharat-biotech , Incovacc-covid-nasal-vaccine-booster , Incovacc , Ovid , Accine , Oronavirus , Ovishield , Ovaxin

Covid vaccine deaths: Centre says immunisation is voluntary, people must make 'informed decisions'

Holding the government responsible for vaccination-related deaths was ‘not legally sustainable’, said the health ministry.

Hyderabad , Andhra-pradesh , India , Karnataka , Argentina , Brazil , Paraguay , Chile , Colombia , Canada , Alpha-marackar , Venugopalan-govindan

COVID: 50 million Covaxin doses set to expire early 2023 due to poor off take

Covaxin news: In April this year, the World health Organization said it confirmed the suspension of supply of Covaxin through UN procurement agencies and recommended that countries using the vaccine take action as appropriate.

India , Brazil , Brazilian , Bharat , Precisa-medicamentos , Envixia-pharmaceuticals , World-health-organization , Central-drugs-standard-control-organisation , Google-news , Image-source , Bharat-biotech , Covaxin-news

Covid-19: Omicron's XBB variant emerges as dominant in India, TN tops

The XBB subvariant of Covid-19's Omicron variant is fast emerging as the dominant in India, with nine states reporting cases of it

Karnataka , India , Delhi , Odisha , Orissa , Puducherry , Pondicherry , Chennai , Tamil-nadu , West-bengal , Wellness